RMDResMed
Price
-15%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality strong, no red flags, undemanding price, growth steady, the market undecided.
We are a global leader in digital health and cloud-connected medical devices. We design innovative solutions to treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, chronic obstructive pulmonary disease, or COPD, and other chronic diseases. Our comprehensive residential care software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice.
In the company’s own words · 10-K filed Aug 8, 2025 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
ResMed (RMD) reported revenue of $1.46B in Q4 2026 (quarter ended Jun 30, 2026), up 8.6% from the same quarter a year earlier. That came with a gross margin of 59% and net income of $383M (26% of revenue). For the full year FY2026, revenue was $5.65B (+9.9% year on year) and net income $1.52B. Its largest product in Q4 2026 was Sleep And Breathing Health at $1.29B, 88% of the disclosed total, well ahead of Residential Care Software at 12%. The next results filing is expected around Oct 29, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 1, 2026On August 31, 2026, ResMed Inc. (the “Company”) entered into an accelerated share repurchase agreement (the “ASR Agreement”) with Citibank, N.A. (“Citibank”) to repurchase $450.0 million of the Company’s shares of common stock, par value $0.004 per share (“Common Stock”)Other event · Form 8-K
- Aug 17, 2026Dismissal of Previous Independent Registered Public Accounting Firm KPMG LLP (“KPMG”) was previously the principal accountants for ResMed Inc. (the “Company” or “Resmed”)Auditor change · Form 8-K
- Aug 6, 2026On August 6, 2026, we announced that our board of directors declared a quarterly cash dividend of US $0.66 per share, representing an increase of 10% over the previous quarterly dividend.Earnings release · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $1.46BThe company’s own SEC segment disclosure.
- Sleep And Breathing Health$1.29B88%
- Residential Care Software$171.9M12%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Instruments & Supplies
The closest names by size in the same industry